Michael Johns

ICO Marketing and Public Relations Strategy and Implementation

Michael Johns is a growth-oriented executive, consultant and globally-recognized thought leader on the business, technology, and public policy trends transforming 21st century economies and governments worldwide. Michael provides management, sales, marketing, and public, government and investor relations counsel to dozens of ICOs and blockchain, cryptocurrency, and fast-growing companies and startups in the finance, technology, healthcare, and other industry sectors globally. He has over two decades of experience in Fortune 1000 executive management capacities and in managing divisional lines of business. As divisional president of a global medical device company, Michael grew divisional revenue from $3.8 million to $30 million in three years and managed a division with over 200 internal and external employees. Michael also has executive-level and management experience at three Fortune 1000 corporations. He was a member of the executive management team of Gentiva Health Services (NASDAQ: GTIV), the nation's largest home health and specialty pharmaceutical company, where he managed global marketing, communications, and investor relations functions for the company. He also managed the marketing and customer service functions for the medical supply division of McKesson (NYSE:MCK), the world's largest healthcare corporation, and corporate communications functions for Eli Lilly and Company (NYSE:LLY). In 2009, he was one of several founders of the U.S. Tea Party movement, the largest and most influential grassroots political movement in American history. He also has served previously as a White House speechwriter to the President of the United States, as a senior aide to a U.S. Senator and Governor, and as a foreign policy analyst at one of the world's most influential public policy research institutes. He holds a Bachelors in Business Administration from the University of Miami, where he majored in economics and graduated with honors. Phone/text: (609) 670-8142